Clinical Trial Update: Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of all-trans retinoic acid (ATRA) and cemiplimab in advanced leiomyosarcoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leiomyosarcoma
• Sarcoma

Drugs mentioned

• All-trans Retinoic Acid (all-trans retinoic acid)
• Cemiplimab (cemiplimab)

Snippet

Sponsor: Gabriel Tinoco | Conditions: Leiomyosarcoma, Sarcoma | Phase 2 | Status: RECRUITING